Fundamental Data for BMY

Bristol-Myers Squibb Company is a global leader in the research and development of innovative lifesaving and life-enhancing treatments for heart disease; high blood pressure; stroke; diabetes; cancer; HIV/AIDS and other infectious diseases; depression, schizophrenia and other mental disorders; pain; and other conditions.

# Employees: 35000

Address: 345 Park Avenue,New York,NY,USA

Phone: 212-546-4000

Fax: 212-546-4020

Website: www.bms.com

Email:

Sector: Medical

Industry: MED-DRUGS

Executive Officers

James M. Cornelius (Chmn.; C.E.O.)

Stephen E. Bear (Sr. V.P.; Corp. Staff; Human Res.)

Anthony C. Hooper (Presi.; U.S. Pharmaceuticals)

Robert T. Zito (Sr. V.P.; Corp. & Buss.)

Sandra Leung (Sr. V.P.; Gen. Counsl.; Corp. Staff,)

Dividend

Ex-Dividend Date: 9/30/2009

Annual Dividend: $1.24

Current Dividend Yield: $4.89

Dividend Paid (3 months): $0.31

Indicated Dividend: $0.61

Earnings

Last Earnings Date: 9/30/2009

Next Earnings Date(Expected): 1/26/2010

Mean EPS (Next Qtr): $0.47

Mean EPS (Year): $2.03

Mean Estimate(Long Term): $7.26

P/E Ratio(Based on EPS estimate): 12.520

Number of Estimates: 18

Shares Performance

Period	BMY	Compare to S&P
YTD	9.16 %	-9.66 %
4 Weeks	16.42 %	10.52 %
12 Weeks	15.36 %	7.43 %

Shares Information

Analyst Coverage: Y

Avg Volume: 16746712

Shares Outstanding: 1980M

Market Cap: $50.28B

52 Week High: $25.65

52 Week Low: $17.51

P/E Ratio: 12.560

PEG Ratio: 1.720

Split: On 3/1/1999 BMY split by factor of 2.000

Earnings Performance

EPS Growth in Last Quarter: -7.14 %

EPS Growth in Last Year: 13.04 %

Sales Growth in Last Quarter: 1.91 %

Sales Growth in Last Quarter: 4.43 %

Financials

Qtr Book Value: $3.50

Cash Flow/Share: $11.74

Change in Payout Ratio: -0.170

Price/Sales: 2.380